This study is testing a new medicine, SNV1521, for people with advanced cancers. The researchers want to find out if SNV1521 is safe, well-tolerated, and effective in treating solid tumors. They are investigating different doses in order to find the most effective and safe one. They are also investigating whether it can be combined with other cancer therapies.
Advanced Solid Tumor
This study is testing a new medicine, SNV1521, for people with advanced cancers. The researchers want to find out if SNV1521 is safe, well-tolerated, and effective in treating solid tumors. They are investigating different doses in order to find the most effective and safe one. They are also investigating whether it can be combined with other cancer therapies.
SNV1521 in Participants with Advanced Solid Tumors
-
Yale University, New Haven, Connecticut, United States, 06520
Thomas Jefferson University, Philadelphia, Pennsylvania, United States, 19144
Sarah Cannon Research Institute, Nashville, Tennessee, United States, 37203
The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States, 77030
START Center for Cancer Care, West Valley City, Utah, United States, 84119
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Synnovation Therapeutics, Inc.,
2026-12